Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.35 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2478903 | 0.80 | IDO1 (0.45) | IDO1TSHRTAAR1PPARGPPARA | |
| SCHEMBL5761538 | 0.77 | IDO1 (0.42) | IDO1TAAR1PPARGPPARACYP2D6 | |
| SCHEMBL7442131 | 0.76 | IDO1 (0.47) | IDO1TAAR1CYP2D6SLC6A2SLC6A4 | |
| SCHEMBL7535391 | 0.74 | IDO1 (0.48) | IDO1TSHRTAAR1CYP1A2CYP2D6 | |
| SCHEMBL7654314 | 0.74 | AR (0.35) | TSHRHSD17B10L3MBTL1ALDH1A1NPSR1 | |
| Hydrogen Sulfide SCHEMBL27896698 | 0.73 | KMT2A (0.50) | PPARGPPARACYP2D6SLC6A2SLC6A4 | |
| SCHEMBL5077192 | 0.73 | KMT2A (0.37) | CYP2D6CYP2C19L3MBTL1KMT2A | |
| SCHEMBL4685387 | 0.73 | GABRA1 (0.52) | IDO1TSHRTAAR1PPARGPPARA | |
| SCHEMBL113325 | 0.73 | TAAR1 (0.48) | TAAR1PPARGPPARACYP2D6SLC6A2 | |
| Methoxymethane SCHEMBL27754277 | 0.72 | GABRA1 (0.47) | IDO1TSHRTAAR1PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2994444-B1 | OLIGOMERISATION OF ETHYLENE TO MIXTURES OF 1-HEXENE AND 1-OCTENE | SASOL TECH PTY LTD (ZA) | 2023-04-12 | — | — | EP | disclosed |
| US-9533922-B2 | Oligomerisation of ethylene to mixtures of 1-hexene and 1-octene | SASOL TECHNOLOGY (PROPRIETARY) LIMITED (ZA) | 2017-01-03 | — | — | US | disclosed |
| US-20160083311-A1 | OLIGOMERISATION OF ETHYLENE TO MIXTURES OF 1-HEXENE AND 1-OCTENE | SASOL TECHNOLOGY (PROPRIETARY LIMITED) (ZA) | 2016-03-24 | — | — | US | disclosed |
| US-6365616-B1 | TRANSPLANT REJECTION | SENTRON MEDICAL, INC. | 2002-04-02 | — | — | US | disclosed |
| EP-1112072-A2 | METHIMAZOLE DERIVATIVES AND TAUTOMERIC CYCLIC THIONES TO TREAT AUTOIMMUNE DISEASES | Sentron Medical, Inc. (US) | 2001-07-04 | — | — | EP | disclosed |
| WO-2000012175-A2 | METHIMAZOLE DERIVATIVES AND TAUTOMERIC CYCLIC THIONES TO TREAT AUTOIMMUNE DISEASES | SENTRON MEDICAL, INC. (US) | 2000-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083311-A1 | OLIGOMERISATION OF ETHYLENE TO MIXTURES OF 1-HEXENE AND 1-OCTENE | LIG1, LIG4, PPIP5K2 | IDO1 1315/4885TSHR 3646/4885TAAR1 2120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.